Medical/Pharmaceuticals

Mina J. Bissell Ph.D. & Vectorspace AI Advance New Space Biosciences Division

SAN FRANCISCO, June 23, 2021 /PRNewswire/ -- As the new space race heats up, more humans will be traveling into space than ever before. Spaceflight causes many changes in human health. Humans cannot be sent into space without understanding how to protect and repair human DNA along with tissue re...

2021-06-23 03:16 1537

Global Water Scarcity and Hospitalization Rates Stimulate the Polymeric Membranes Market

The demand for water treatment membranes and medical membranes will drive the global market, says Frost & Sullivan SANTA CLARA, Calif., June 23, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis of the global polymeric membranes market finds that the drive to achieve a circular economy and...

2021-06-23 00:14 1787

Insilico Medicine Raises $255 Million in Series C Financing Led by Warburg Pincus

NEW YORK and HONG KONG, June 22, 2021 /PRNewswire/ -- Insilico Medicine, a global leader in end-to-end artificial intelligence for target discovery, small molecule chemistry, and clinical development, announced that it has closed a $255 million Series C financing led by Warburg Pincus. The financi...

2021-06-22 21:46 3141

Eurofins Discovery and ImmunoPrecise Announce Collaboration to Expand their Antibody Discovery Platform

ST. CHARLES, Mo., June 22, 2021 /PRNewswire/ -- Eurofins Discovery, the leading provider of products and services to the drug discovery industry and a Eurofins Scientific (EUFI.PA) company, and ImmunoPrecise Antibodies (Nasdaq:IPA), the market leader in full-service therapeutic discovery and deve...

2021-06-22 20:28 3102

Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results

HONG KONG, June 22, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financial ...

2021-06-22 19:00 24037

Alfasigma acquires the European license for bentracimab from PhaseBio

BOLOGNA, Italy, 22 giugno 2021 /PRNewswire/ -- Alfasigma has entered into an exclusive licensing agreement with PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), for the commercialization of bentracimab in 49 countries acrossEurope and other key markets. PhaseBio is a biopharmaceutical company focu...

2021-06-22 14:45 1895

INDICAID(R) COVID-19 Rapid Antigen Test certified by Cambodia's Ministry of Health for Disease Control

HONG KONG and PHNOM PENH, Cambodia, June 22, 2021 /PRNewswire/ -- Cambodia's Ministry of Health has approved INDICAID® COVID-19 Rapid Antigen Test for commercialisation as part of the country's efforts in controlling recent spikes of COVID-19 cases in the region. Rapid antigen tests like INDIC...

2021-06-22 09:00 3333

Innovent Announces the Approval of Pemazyre® (pemigatinib) in Taiwan Market for the Treatment of Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement

SAN FRANCISCO and SUZHOU, China, June 22, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...

2021-06-22 08:00 17704

New Patient Guide from NCCN Jumpstarts Important Conversations About Anal Cancer

New and updated patient and caregiver resources from National Comprehensive Cancer Network offer jargon-free, state-of-the-art information on diagnosis, treatment, and surveillance for anal, colon, and rectal cancers. PLYMOUTH MEETING, Pa., June 21, 2021 /PRNewswire/ -- The National Comprehensiv...

2021-06-21 23:36 1513

2021 ASCO - AnchorDx Unveils Robust Validation Result of Multi-cancer Screening Technology AURORA

GUANGZHOU, China, June 21, 2021 /PRNewswire/ -- At this year's American Society of Clinical Oncology (ASCO) Annual Meeting 2021 (June 4-8), AnchorDx, a world-leading developer of cancer screening and early detection solutions, unveiled further validation results on the generalization performance ...

2021-06-21 23:19 502

The Pressing Need for Early Detection of Mucormycosis during COVID-19

DONGGUAN, China, June 21, 2021 /PRNewswire/ -- Mucormycosis or black fungus, a devastating infection that soars inIndia during COVID-19 has seized global attention. Recently, the country's mucormycosis cases reached over 57,150 and resulted in54% mortality

2021-06-21 20:00 2696

RedHill Biopharma Announces Presentation of Positive Oral Opaganib Phase 2 Data in COVID-19

TEL AVIV, Israel and RALEIGH, NC, June 21, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral o...

2021-06-21 19:00 6993

HUTCHMED Announces NMPA Approval of Surufatinib (Sulanda(R) in China) for Advanced Pancreatic Neuroendocrine Tumors

HONG KONG, June 21, 2021 /PRNewswire/ --  HUTCHMED (China) Limited ("HUTCHMED ") (Nasdaq/AIM: HCM) today announces that surufatinib has been granted approval for drug registration by the National Medical Products Administration ofChina ("NMPA") for the treatment of adv...

2021-06-21 15:15 3472

CStone announces first prescriptions of precision therapy GAVRETO® (pralsetinib) issued across China for the treatment of adults with locally advanced or metastatic RET fusion-positive non-small cell lung cancer after platinum-based chemotherapy

SUZHOU, China, June 21, 2021 /PRNewswire/ -- GAVRETO® (pralsetinib), a precision therapy discovered by CStone Pharmaceuticals' partner Blueprint Medicines, had the first batch of prescriptions issued at Guangdong Province People's Hospital and around 100 other hospitals acrossChina. GAVRETO is al...

2021-06-21 13:06 2612

Study Results of Sintilimab in Combination with Bevacizumab Biosimilar IBI305 for the First-Line Treatment of Hepatocellular Carcinoma Published in The Lancet Oncology

SAN FRANCISCO and SUZHOU, China, June 21, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...

2021-06-21 08:00 5101

EAN Congress: COVID-19 leads to significant cognitive and behavioural problems in patients

VIENNA, June 21, 2021 /PRNewswire/ -- COVID-19 patients suffer from cognitive and behavioural problems two months after being discharged from hospital, a new study presented at the 7th Congress of the European Academy of Neurology has found[1]. Issues with memory, spatial awareness and informati...

2021-06-21 06:01 1731

CARsgen Therapeutics officially listing on HKEX

HONG KONG, June 19, 2021 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (the "Company", stock code: 2171.HK) today announced that the Company's Shares have been traded on the Main Board of The Stock Exchange of Hong Kong Limited under the stock code "2171.HK".

2021-06-19 02:57 8688

deCODE genetics: Predicting the probability of death

REYKJAVIK, Iceland, June 18, 2021 /PRNewswire/ -- Scientists from deCODE genetics have developed a predictor based on protein measurements in blood samples that predicts the time to all-cause death better than traditional risk factors.

2021-06-18 17:00 2661

China and India Combat Coronavirus Pandemic Together: Online Ceremony Held for the Handover of Medical Supplies to Aid India

HONG KONG, June 18, 2021 /PRNewswire/ -- On 11 June 2021, an online ceremony was held for the handover of anti-pandemic supplies to aidIndia. Medical supplies toIndia included 135 oxygen concentrators, 5 ventilators and 3,300 KN95 masks. Present at the event were Tang Guocai, Chinese Consul Gener...

2021-06-18 16:15 1596

Latest testing confirms Viraleze highly effective against Alpha, Beta and Gamma COVID variants

MELBOURNE, Australia, June 18, 2021 /PRNewswire/ -- New data released today shows thatAustralia's Viraleze™ anti-COVID nasal spray is more than 99.9% effective against three of the four deadliest variants of the SARS-CoV-2 virus. ...

2021-06-18 14:16 14220
1 ... 236237238239240241242 ... 382